337 related articles for article (PubMed ID: 19438479)
21. "In vitro" correction of the severe factor V deficiency-related coagulopathy by a novel plasma-derived factor V concentrate.
Bulato C; Novembrino C; Anzoletti MB; Spiezia L; Gavasso S; Berbenni C; Tagariello G; Farina C; Nardini I; Campello E; Peyvandi F; Simioni P
Haemophilia; 2018 Jul; 24(4):648-656. PubMed ID: 29578313
[TBL] [Abstract][Full Text] [Related]
22. Inhibitor to factor V in severe factor V congenital deficiency. A case report.
Mazzucconi MG; Solinas S; Chistolini A; Motta M; Mariani G
Nouv Rev Fr Hematol (1978); 1985; 27(5):303-5. PubMed ID: 4080539
[TBL] [Abstract][Full Text] [Related]
23. A new look at blood coagulation factor V.
Camire RM
Curr Opin Hematol; 2011 Sep; 18(5):338-42. PubMed ID: 21730834
[TBL] [Abstract][Full Text] [Related]
24. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency.
Cmolik BL; Spero JA; Magovern GJ; Clark RE
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):222-7; discussion 227-8. PubMed ID: 8429648
[TBL] [Abstract][Full Text] [Related]
25. Spectrum of changes in endogenous thrombin potential due to heritable disorders of coagulation.
Ghosh K; Mota L; Shetty S; Kulkarni B
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):577-80. PubMed ID: 18685441
[TBL] [Abstract][Full Text] [Related]
26. Modelling and expression studies of two novel mutations causing factor V deficiency.
Delev D; Pavlova A; Heinz S; Blaise MC; Chandra T; Poetsch B; Seifried E; Oldenburg J
Thromb Haemost; 2008 Nov; 100(5):766-72. PubMed ID: 18989519
[TBL] [Abstract][Full Text] [Related]
27. [Gene analysis of five inherited factor V deficiency cases].
Cao LJ; Wang ZY; Su YH; Yang HY; Zhao XJ; Zhang W; Yu ZQ; Bai X; Ruan CG
Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):145-8. PubMed ID: 18788609
[TBL] [Abstract][Full Text] [Related]
28. Combined Factor V and Factor VIII Deficiency.
Spreafico M; Peyvandi F
Semin Thromb Hemost; 2009 Jun; 35(4):390-9. PubMed ID: 19598067
[TBL] [Abstract][Full Text] [Related]
29. Clinical and laboratory diagnosis of autoimmune factor V inhibitors: A single institutional experience.
Sridharan M; Fylling KA; Ashrani AA; Chen D; Marshall AL; Hook CC; Cardel LK; Nichols WL; Pruthi RK
Thromb Res; 2018 Nov; 171():14-21. PubMed ID: 30227314
[TBL] [Abstract][Full Text] [Related]
30. Coagulation factor V.
Duga S; Asselta R; Tenchini ML
Int J Biochem Cell Biol; 2004 Aug; 36(8):1393-9. PubMed ID: 15147718
[TBL] [Abstract][Full Text] [Related]
31. Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.
Tracy PB; Giles AR; Mann KG; Eide LL; Hoogendoorn H; Rivard GE
J Clin Invest; 1984 Oct; 74(4):1221-8. PubMed ID: 6480825
[TBL] [Abstract][Full Text] [Related]
32. [Studies on hereditary deficiency of coagulation factor V].
Xie F; Cheng F; Zhu X
Zhonghua Xue Ye Xue Za Zhi; 2001 Sep; 22(9):453-6. PubMed ID: 11758222
[TBL] [Abstract][Full Text] [Related]
33. A case of coagulation factor V deficiency caused by compound heterozygous mutations in the factor V gene.
Yamakage N; Ikejiri M; Okumura K; Takagi A; Murate T; Matushita T; Naoe T; Yamamoto K; Takamatsu J; Yamazaki T; Hamaguchi M; Kojima T
Haemophilia; 2006 Mar; 12(2):172-8. PubMed ID: 16476093
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of coagulation factor V deficiency caused by the R1698W inter-domain mutation.
Calzavarini S; Villoutreix BO; Lunghi B; Livaja R; Bernardi F; Dahlbäck B
Thromb Haemost; 2013 Jul; 110(1):31-8. PubMed ID: 23616041
[TBL] [Abstract][Full Text] [Related]
35. High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors.
de Raucourt E; Barbier C; Sinda P; Dib M; Peltier JY; Ternisien C
Am J Hematol; 2003 Nov; 74(3):187-90. PubMed ID: 14587047
[TBL] [Abstract][Full Text] [Related]
36. [A case positive for the inhibitor for coagulation factor V].
Nakagoshi R; Takamiya O; Nakata S; Ishikawa S; Higuchi Y; Okumura N; Ogiso Y
Rinsho Byori; 1999 Oct; 47(10):971-5. PubMed ID: 10590673
[TBL] [Abstract][Full Text] [Related]
37. Congenital coagulation factor V deficiency with intracranial hemorrhage.
Yang J; Mao H; Sun L
J Clin Lab Anal; 2022 Nov; 36(11):e24705. PubMed ID: 36125894
[TBL] [Abstract][Full Text] [Related]
38. Factor V Has Anticoagulant Activity in Plasma in the Presence of TFPIα: Difference between FV1 and FV2.
van Doorn P; Rosing J; Duckers C; Hackeng TM; Simioni P; Castoldi E
Thromb Haemost; 2018 Jul; 118(7):1194-1202. PubMed ID: 29864781
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of a novel missense mutation, His147Arg, in A1 domain of FV protein causing type II deficiency.
Liu HC; Lin TM; Eng HL; Lin YT; Shen MC
Thromb Res; 2014 Jul; 134(1):153-9. PubMed ID: 24787990
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of solvent/detergent plasma after storage at 2-8 °C for 5 days in comparison to other plasma products to improve factor V levels in factor V deficient plasma.
Cushing MM; Asmis L; Calabia C; Rand JH; Haas T
Transfus Apher Sci; 2016 Aug; 55(1):114-9. PubMed ID: 27156966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
